N. Heimburger

3.2k total citations
93 papers, 2.5k citations indexed

About

N. Heimburger is a scholar working on Hematology, Molecular Biology and Cancer Research. According to data from OpenAlex, N. Heimburger has authored 93 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 24 papers in Molecular Biology and 18 papers in Cancer Research. Recurrent topics in N. Heimburger's work include Blood Coagulation and Thrombosis Mechanisms (23 papers), Protease and Inhibitor Mechanisms (18 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers). N. Heimburger is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (23 papers), Protease and Inhibitor Mechanisms (18 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers). N. Heimburger collaborates with scholars based in Germany, United States and Sweden. N. Heimburger's co-authors include H. Haupt, H. Pelzer, A. Schwarz, Theodor Kranz, T. Stief, K. Heide, S Baudner, H. E. Schultze, Jürgen Römisch and Hans Fritz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemical Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

N. Heimburger

89 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Heimburger Germany 25 924 724 453 447 303 93 2.5k
Raymund Machovich Hungary 27 929 1.0× 459 0.6× 616 1.4× 573 1.3× 146 0.5× 107 2.3k
Ian MacGregor United Kingdom 26 781 0.8× 712 1.0× 431 1.0× 366 0.8× 138 0.5× 88 2.2k
E. Regoeczi Canada 33 968 1.0× 1.2k 1.6× 658 1.5× 255 0.6× 223 0.7× 140 3.4k
BC Furie United States 25 1.4k 1.5× 728 1.0× 298 0.7× 245 0.5× 293 1.0× 39 3.1k
M.W.C. Hatton Canada 25 526 0.6× 585 0.8× 361 0.8× 213 0.5× 104 0.3× 69 1.8k
Alan R. Stafford Canada 32 935 1.0× 843 1.2× 412 0.9× 233 0.5× 348 1.1× 74 2.6k
Shosuke Okamoto Japan 22 697 0.8× 592 0.8× 183 0.4× 295 0.7× 216 0.7× 81 2.4k
Jürgen Römisch Germany 28 869 0.9× 1.4k 1.9× 238 0.5× 282 0.6× 166 0.5× 76 2.7k
J. Dawes United Kingdom 30 891 1.0× 634 0.9× 615 1.4× 292 0.7× 178 0.6× 133 3.4k
Colin Longstaff United Kingdom 30 980 1.1× 739 1.0× 818 1.8× 510 1.1× 205 0.7× 96 3.0k

Countries citing papers authored by N. Heimburger

Since Specialization
Citations

This map shows the geographic impact of N. Heimburger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Heimburger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Heimburger more than expected).

Fields of papers citing papers by N. Heimburger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Heimburger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Heimburger. The network helps show where N. Heimburger may publish in the future.

Co-authorship network of co-authors of N. Heimburger

This figure shows the co-authorship network connecting the top 25 collaborators of N. Heimburger. A scholar is included among the top collaborators of N. Heimburger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Heimburger. N. Heimburger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heimburger, N. & Hermann Erich Karges. (2015). Strategies to Produce Virus-Safe Blood Derivatives. Current studies in hematology and blood transfusion. 23–33. 1 indexed citations
2.
Heimburger, N.. (2002). From Cryoprecipitate to Virus-Safe High-Purity Concentrate. Seminars in Thrombosis and Hemostasis. 28(S1). 25–30. 1 indexed citations
3.
Mingers, Anne-Marie, et al.. (1997). Homozygous Type I Plasminogen Deficiency. Seminars in Thrombosis and Hemostasis. 23(3). 259–269. 72 indexed citations
4.
Römisch, Jürgen, et al.. (1991). In-vivo antithrombotic potency of Placenta Protein 4 (annexin V). Thrombosis Research. 61(2). 93–104. 59 indexed citations
5.
Römisch, Jürgen, et al.. (1990). Anticoagulant properties of placenta protein 4 (Annexin V). Thrombosis Research. 60(5). 355–366. 41 indexed citations
6.
Römisch, Jürgen & N. Heimburger. (1990). Purification and Characterization of Six Annexins from Human Placenta. Biological Chemistry Hoppe-Seyler. 371(1). 383–388. 35 indexed citations
7.
Radtke, Klaus-Peter, et al.. (1990). Isolation of Plasminogen Activator Inhibitor-2 (PAI-2) from Human Placenta. Evidence for Vltronectin/PAI-2 Complexes in Human Placenta Extract. Biological Chemistry Hoppe-Seyler. 371(2). 1119–1128. 13 indexed citations
8.
Stief, T., Rudolf Marx, & N. Heimburger. (1989). Oxidized fibrin(ogen) derivatives enhance the activity of tissue type plasminogen activator. Thrombosis Research. 56(2). 221–228. 19 indexed citations
9.
Stief, T. & N. Heimburger. (1988). Inactivation of Serine Proteinase Inhibitors (Serpins) in Human Plasma by Reactive Oxidants. Biological Chemistry Hoppe-Seyler. 369(2). 1337–1342. 18 indexed citations
10.
Stüber, Werner, et al.. (1988). Synthesis of a tripeptide with a C‐terminal nitrile moiety and the inhibition of proteinases. International journal of peptide & protein research. 31(1). 63–70. 20 indexed citations
11.
Stief, T., et al.. (1988). Oxidative inactivation of purified human alpha-2-antiplasmin, antithrombin III, and C1-inhibitor. Thrombosis Research. 49(6). 581–589. 49 indexed citations
12.
Stief, T., Klaus-Peter Radtke, & N. Heimburger. (1987). Inhibition of Urokinase by Protein C-Inhibitor (PCI). Evidence for Identity of PCI and Plasminogen Activator Inhibitor 3. Biological Chemistry Hoppe-Seyler. 368(2). 1427–1434. 48 indexed citations
13.
14.
Heimburger, N.. (1982). Fortschritte in der behandlung der haemophilie A: Ein hepatitissicheres Faktor-VIII-Konzentrat. Annals of Hematology. 44(4). 249–251. 3 indexed citations
15.
Saito, Hidehiko, et al.. (1982). Reduced histidine-rich glycoprotein levels in plasma of patients with advanced liver cirrhosis. The American Journal of Medicine. 73(2). 179–182. 66 indexed citations
16.
Gramse, M., et al.. (1977). In vivo effects of human granulocyte neutral proteases on blood coagulation in green monkeys (cercopithecus aetiops). Thrombosis and Haemostasis. 5 indexed citations
17.
Haupt, H. & N. Heimburger. (1972). [Human serum proteins with high affinity for carboxymethylcellulose. I. Isolation of lysozyme, C1q and 2 hitherto unknown -globulins].. PubMed. 353(7). 1125–32. 22 indexed citations
18.
Hochstrasser, K, et al.. (1972). [Demonstration and quantitative determination of complexes between leukocyte protease and 1 -antitrypsin in body secretions and body fluids].. PubMed. 353(7). 1120–4. 4 indexed citations
19.
Heimburger, N.. (1972). Human serum proteins with a high affinity for carboxymethyl-cellulose II: Physicochemical and immunological characterization of a histidine-rich 3.8S α2-glycoprotein (CM protein I). Hoppe-Seyler's Z. Medical Entomology and Zoology. 353. 1133–1140. 8 indexed citations
20.
Heide, K., N. Heimburger, & H. Haupt. (1965). An inter-alpha trypsin inhibitor of human serum. Clinica Chimica Acta. 11(1). 82–85. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026